Literature DB >> 9727001

A hyperprostaglandin E syndrome mutation in Kir1.1 (renal outer medullary potassium) channels reveals a crucial residue for channel function in Kir1.3 channels.

C Derst1, E Wischmeyer, R Preisig-Müller, A Spauschus, M Konrad, P Hensen, N Jeck, H W Seyberth, J Daut, A Karschin.   

Abstract

Loss of function mutations in kidney Kir1.1 (renal outer medullary potassium channel, KCNJ1) inwardly rectifying potassium channels can be found in patients suffering from hyperprostaglandin E syndrome (HPS), the antenatal form of Bartter syndrome. A novel mutation found in a sporadic case substitutes an asparagine by a positively charged lysine residue at amino acid position 124 in the extracellular M1-H5 linker region. When heterologously expressed in Xenopus oocytes and mammalian cells, current amplitudes from mutant Kir1.1a[N124K] channels were reduced by a factor of approximately 12 as compared with wild type. A lysine at the equivalent position is present in only one of the known Kir subunits, the newly identified Kir1.3, which is also poorly expressed in the recombinant system. When the lysine residue in guinea pig Kir1.3 (gpKir1.3) isolated from a genomic library was changed to an asparagine (reverse HPS mutation), mutant channels yielded macroscopic currents with amplitudes increased 6-fold. From single channel analysis it became apparent that the decrease in mutant Kir1.1 channels and the increase in mutant gpKir1.3 macroscopic currents were mainly due to the number of expressed functional channels. Coexpression experiments revealed a dominant-negative effect of Kir1.1a[N124K] and gpKir1.3 on macroscopic current amplitudes when coexpressed with wild type Kir1.1a and gpKir[K110N], respectively. Thus we postulate that in Kir1.3 channels the extracellular positively charged lysine is of crucial functional importance. The HPS phenotype in man can be explained by the lower expression of functional channels by the Kir1. 1a[N124K] mutant.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9727001     DOI: 10.1074/jbc.273.37.23884

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Molecular mechanism of a COOH-terminal gating determinant in the ROMK channel revealed by a Bartter's disease mutation.

Authors:  Thomas P Flagg; Dana Yoo; Christopher M Sciortino; Margaret Tate; Michael F Romero; Paul A Welling
Journal:  J Physiol       Date:  2002-10-15       Impact factor: 5.182

Review 2.  Molecular diversity and regulation of renal potassium channels.

Authors:  Steven C Hebert; Gary Desir; Gerhard Giebisch; Wenhui Wang
Journal:  Physiol Rev       Date:  2005-01       Impact factor: 37.312

3.  C-terminal determinants of Kir4.2 channel expression.

Authors:  Wade L Pearson; Serguei N Skatchkov; Misty J Eaton; Colin G Nichols
Journal:  J Membr Biol       Date:  2007-04-28       Impact factor: 1.843

4.  Female ROMK null mice manifest more severe Bartter II phenotype on renal function and higher PGE2 production.

Authors:  Qingshang Yan; Xinbo Yang; Alessandra Cantone; Gerhard Giebisch; Steven Hebert; Tong Wang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-06-25       Impact factor: 3.619

5.  pH gating of ROMK (K(ir)1.1) channels: control by an Arg-Lys-Arg triad disrupted in antenatal Bartter syndrome.

Authors:  U Schulte; H Hahn; M Konrad; N Jeck; C Derst; K Wild; S Weidemann; J P Ruppersberg; B Fakler; J Ludwig
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

6.  Absence of small conductance K+ channel (SK) activity in apical membranes of thick ascending limb and cortical collecting duct in ROMK (Bartter's) knockout mice.

Authors:  Ming Lu; Tong Wang; Qingshang Yan; Xinbo Yang; Ke Dong; Mark A Knepper; WenHui Wang; Gerhard Giebisch; Gary E Shull; Steven C Hebert
Journal:  J Biol Chem       Date:  2002-07-18       Impact factor: 5.157

7.  A mutation linked with Bartter's syndrome locks Kir 1.1a (ROMK1) channels in a closed state.

Authors:  T P Flagg; M Tate; J Merot; P A Welling
Journal:  J Gen Physiol       Date:  1999-11       Impact factor: 4.086

8.  The First Scube3 Mutant Mouse Line with Pleiotropic Phenotypic Alterations.

Authors:  Helmut Fuchs; Sibylle Sabrautzki; Gerhard K H Przemeck; Stefanie Leuchtenberger; Bettina Lorenz-Depiereux; Lore Becker; Birgit Rathkolb; Marion Horsch; Lillian Garrett; Manuela A Östereicher; Wolfgang Hans; Koichiro Abe; Nobuho Sagawa; Jan Rozman; Ingrid L Vargas-Panesso; Michael Sandholzer; Thomas S Lisse; Thure Adler; Juan Antonio Aguilar-Pimentel; Julia Calzada-Wack; Nicole Ehrhard; Ralf Elvert; Christine Gau; Sabine M Hölter; Katja Micklich; Kristin Moreth; Cornelia Prehn; Oliver Puk; Ildiko Racz; Claudia Stoeger; Alexandra Vernaleken; Dian Michel; Susanne Diener; Thomas Wieland; Jerzy Adamski; Raffi Bekeredjian; Dirk H Busch; John Favor; Jochen Graw; Martin Klingenspor; Christoph Lengger; Holger Maier; Frauke Neff; Markus Ollert; Tobias Stoeger; Ali Önder Yildirim; Tim M Strom; Andreas Zimmer; Eckhard Wolf; Wolfgang Wurst; Thomas Klopstock; Johannes Beckers; Valerie Gailus-Durner; Martin Hrabé de Angelis
Journal:  G3 (Bethesda)       Date:  2016-12-07       Impact factor: 3.154

Review 9.  Disease Associated Mutations in KIR Proteins Linked to Aberrant Inward Rectifier Channel Trafficking.

Authors:  Eva-Maria Zangerl-Plessl; Muge Qile; Meye Bloothooft; Anna Stary-Weinzinger; Marcel A G van der Heyden
Journal:  Biomolecules       Date:  2019-10-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.